Get the latest news, insights, and market updates on SNPS (Synopsys, Inc.). Explore the news page 16 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Assessing Synopsys (SNPS) Valuation After Recent Weakness in Share Performance
Synopsys (SNPS) shares moved slightly higher in Thursday’s trading session, bucking a modest recent pullback. Investors are evaluating how the stock’s fundamentals line up given its past month of weaker performance. See our latest analysis for Synopsys. After an impressive run-up over the past few years, Synopsys shares have cooled off in 2024. The stock registered a 1-year total shareholder return of -27.6 percent and a year-to-date share price return of -17 percent. This reflects a shift in... Nov 11, 2025 - $SNPS
Is Synopsys Attractively Priced After Recent Acquisition Plans and Share Price Drop?
Wondering if Synopsys is a hidden bargain or if the market has already priced in all the upside? This article will help you make sense of whether the stock is looking attractively valued or potentially overhyped right now. Recently, Synopsys shares have taken a breather, down 3.7% this week and 8.7% over the last month. This has pushed their year-to-date move to -17.0% and a striking -27.6% over the past year, even after strong longer-term gains of 19.9% over three years and a remarkable... Nov 11, 2025 - $SNPS
Astera Labs Announces Financial Results for the Third Quarter of Fiscal Year 2025
Record quarterly revenue of $230.6 million, up 20% QoQ and 104% YoY Strong Q3 revenue growth driven by new AI platform ramps featuring multiple product familiesScorpio fabric switch design wins expand to several platforms at multiple hyperscaler customers SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced preliminary financial results for the third quarter o Nov 4, 2025 - $SNPS
What Catalysts Could Shift the Narrative for Synopsys as Analysts Weigh New Risks and Opportunities
Synopsys stock has drawn renewed analyst attention following a recent update to its price target and valuation outlook. While the fair value per share remains steady at $556.4, analysts have made subtle tweaks to their models, including a marginally lower discount rate. This reflects slightly reduced risk perceptions along with sustained expectations for future revenue growth. Stay tuned to learn how investors and analysts are responding to these shifts, and how you can monitor the evolving... Nov 1, 2025 - $SNPS
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple